label,sentence,pubmed_id,labeler
P,37 ||| MATERIALS AND METHODS ||| 1.3 ||| Patients were eligible if 1) they were aged 18-70 yr; 2) they had ischemic chest pain for > 30 min; 3) they were admitted to hospital < 24 hr after the onset of chest pain; 4) electrocardiography (ECG) showed ST segment elevation > 1 mm in two consecutive leads in the limb leads or > 2 mm in the precordial leads; and 5) they could be enrolled in the study < 72 hr after successful revascularization (defined as residual stenosis < 30% of the infarct-related artery [IRA]).,24431901,lingtaiwei
P,96 ||| MATERIALS AND METHODS ||| 1.62 ||| Study hypothesis is to demonstrate the superiority of MSCs treatment compared with control group.,24431901,lingtaiwei
P,4 |||  ||| 0.4 ||| Eighty patients with AMI after successful reperfusion therapy were randomly assigned and received an intracoronary administration of autologous BM-derived MSCs into the infarct related artery at 1 month.,24431901,lingtaiwei
P,"38 ||| MATERIALS AND METHODS ||| 1.4 ||| We excluded patients with cardiogenic shock, life-threatening arrhythmia, advanced renal or hepatic dysfunction, history of previous coronary artery bypass graft, history of hematologic disease and malignancy, major bleeding requiring blood transfusion, stroke or transient ischemic attack in the previous 6 months, use of corticosteroids or antibiotics during the previous month, major surgical procedure in the previous 3 months, cardiopulmonary resuscitation for > 10 min within the previous 2 weeks, positive skin test for penicillin, positive result for viral markers (human immunodeficiency virus [HIV], hepatitis B virus [HBV], hepatitis C virus [HCV] and Venereal Disease Research Laboratory [VDRL] test), pregnant woman and possible candidate for pregnancy.",24431901,lingtaiwei
I,"42 ||| MATERIALS AND METHODS ||| 1.8 ||| Mononuclear cells were separated from the BM by density gradient centrifugation (HIS-TOPAQUE-1077; Sigma-Aldrich, St. Louis, MO, USA) and washed with phosphate-buffered saline (PBS).",24431901,lingtaiwei
I,"189 ||| DISCUSSION ||| 4.41 ||| More patients in control group (5/36, 13.9%) were excluded than those in treatment group (1/33, 3.0%).",24431901,lingtaiwei
O,1 |||  ||| 0.1 ||| Recent studies suggest that the intracoronary administration of bone marrow (BM)-derived mesenchymal stem cells (MSCs) may improve left ventricular function in patients with acute myocardial infarction (AMI).,24431901,lingtaiwei
O,152 ||| DISCUSSION ||| 4.4 ||| Our results met the primary endpoint of â‰¥ 4.3% improvement in LVEF compared with the control group.,24431901,lingtaiwei
